Newark, California
United States
3
2022-01-27
3
2022-08-23
These are the the leading inventors for applications assigned to TeneoOne, Inc.:
TeneoOne, Inc. based in Newark, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
CD3 binding antibodies
#2 | 2021-11-04 ✅ Patent 11,186,639 granted on 2021-11-30Multispecific heavy chain antibodies with modified heavy chain constant regions
#3 | 2020-05-21 ✅ Patent 11,427,642 granted on 2022-08-30Anti-BCMA heavy chain-only antibodies
Also check out TeneoOne, Inc.'s (Newark, United States) applicant profile with 3 patent applications submitted.
384858 ⎘